FDA Inspection 1314592 — The Gillette Company

The Gillette Company — FEI 1417171

The FDA completed an inspection of The Gillette Company on March 24, 2026 in North Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 24, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
North Chicago, IL (United States)